Ogicef-S 375 Injection
Marketer
Logimed Pharma Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Ogicef-S 375 Injection
Cefixime and Sulbactam injection (375mg) is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits bacterial proliferation, thus controlling infection spread. Administration must be strictly under medical guidance; adherence to the prescribed dosage schedule is crucial. Complete the full course of treatment, regardless of symptom improvement, as premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (skin rashes, pruritus, edema, dyspnea). Prior to commencing treatment, inform your physician of all current medications and pre-existing health conditions. Pregnant or lactating individuals require specific medical advice before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, avoid driving if experiencing somnolence or vertigo. Adequate rest, a balanced diet, and ample hydration contribute to faster recovery. Your physician may request laboratory tests to monitor treatment effectiveness.
Uses of Ogicef-S 375 Injection
Infections caused by bacteria
Major Benefits of Ogicef-S 375 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ogicef-S 375 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ogicef-S 375 Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Ogicef-S 375 Injection works:
Ceftriaxone and Sulbactam, the components of Ogicef-S 375 Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol co-ingestion with Ogicef-S 375 Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ogicef-S 375 is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, research involving human subjects is currently insufficient.
Breast feedingCAUTION
Administering Ogicef-S 375 Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Ogicef-S 375 Injection can induce drowsiness, visual disturbances, or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Ogicef-S 375 Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
For patients with severe hepatic impairment, administering Ogicef-S 375 Injection requires careful consideration and potential dosage modification. Individuals with mild to moderate liver disease, however, do not typically necessitate dosage alterations of Ogicef-S 375 Injection. Physician consultation is advised.
What if you forget to take Ogicef-S 375 Injection :
Omit a dose of Ogicef-S 375 Injection? Seek medical advice immediately.
Facts to Know About Ogicef-S 375 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently